Pilar Rivera-Ortega
@pilarriveraort1
Respiratory Consultant, subspecialty in Interstitial Lung Diseases #ILD🫁🧬Manchester University NHS Foundation Trust. Tweets=my own🇵🇪🇪🇸🇬🇧 #DEI #RWE #RCTs
ID: 1379784600768110592
https://uk.linkedin.com/in/pilar-rivera-ortega-02435288 07-04-2021 13:14:37
9,9K Tweet
3,3K Followers
5,5K Following
A huge thank you to Sarah Green MP for tabling some Parliamentary Questions on PF & to the Minister for highlighting our work on a national consensus pathway looking to transform ILD and PF care Action for Pulmonary Fibrosis
Pulmonary Hypertension (PH) can be caused by Pulmonary Fibrosis (PF) & can be dangerous as it can cause heart failure. The symptoms of PH can be similar to those of PF. Living with both makes life a lot more difficult. Need more information? Take a look at Action for Pulmonary Fibrosis 💜
Charpentier y Doudna podrían retirar dos de sus patentes #CRISPR en Europa (gestionadas por Caribou Biosciences y ERS Genomics) y adelantarse a la EuropeanPatentOffice que quiere retirarlas por insuficientes detalles descriptivos, según explica Antonio Regalado en MIT Technology Review technologyreview.com/2024/09/25/110…
The ACGS position statement: Rare disease genomic testing in the UK and Ireland: promoting timely and equitable access, is online jmg.bmj.com/content/early/… Collaborative best practice guidance involving Unique NHS Genomic Medicine Service Wales Gene Park Genetic Alliance GenQA (Genomics Quality Assessment) & others🧵
We welcome today's announcement from Health and Social Care Secretary, Wes Streeting on improving access to primary care data for research. This will help to advance healthcare and research innovation. Hear from our CEO Rich Scott👇 Richard Scott Wes Streeting MP
New from American Thoracic Society (ATS)– ATS Sarcoidosis Primer amaedhub.org/3Y9lUFb